|
Information For:
|
Rules of Business Practice for the 2005–2010 USP Board of Trustees13. Executive Vice President and Chief Executive Officer (EVP–CEO)13.01 Responsibilities and Authority of EVP-CEO
13.02 AbsenceIn the event of an unanticipated absence of the EVP–CEO, responsibility for his/her functions shall be assumed in accordance with the interim succession plan for the EVP–CEO reviewed by the Compensation and Continuity Committee pursuant to in Section 11.02(e) above and approved by the Board. The interim successor shall retain such functions until the EVP/CEO re–assumes his/her responsibilities or selection of a new EVP/CEO, as determined by the Board. What's New
White Papers 2010 Convention Become a USP Expert Volunteer More What's New
Follow USP with
|
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||